Patents expiring in 2038

US 9931311

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9932322

Method for producing sulfonyl chloride compound

Takeda Pharmaceutical Company Limited · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9932564

Recombinant isfahan viral vectors

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9933434

Therapeutic antibodies against ROR-1 protein and methods for use of same

The Regents of the University of California · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9931415

Pyrrolobenzodiazepine-antibody conjugates

ADC THERAPEUTICS SA · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9932406

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9931412

Targeted theranostics

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9931334

Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9931389

Genetic attenuation of plasmodium by B9 gene disruption

Sanaria Inc. · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938236

Antiviral agents against HBV infection

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938272

Hydrazine compound as blood coagulation factor Xa inhibitor

North China Pharmaceutical Company., Ltd. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938344

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

PRECISION BIOLOGICS, INC. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937157

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938258

Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938353

Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937192

Combination therapy to treat mycobacterium diseases

SPERO TRINEM, INC. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938589

Compositions and methods for detecting human pegivirus 2 (HPgV-2)

The Regents of the University of California · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937155

Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

Aurigene Discovery Technologies Limited · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937191

Inhibition of HIV infection through chemoprophylaxis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937129

Materials and methods for delivering compositions to selected tissues

The Regents of the University of California · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938582

Recurrent gene fusions in prostate cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938516

Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanine

Sutro Biopharma, Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938526

Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation

The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938345

Human antibodies to PD-L1

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938500

Hemangio-colony forming cells

Astellas Institute for Regenerative Medicine · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938350

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

The Regents of the University of California · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937141

Carcinoma diagnosis and treatment, based on ODC1 genotype

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937243

Sialylated glycoprotein compositions and uses thereof

Ultragenyx Pharmaceutical Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938339

Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938257

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938270

Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor

Addex Pharma, S.A. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938259

Therapeutic compositions and related methods of use

Agios Pharmaceuticals, Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937256

Hydrogels for delivery of therapeutic compounds

The Board of Regents of the University of Texas System · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937222

Modulators of complement activity

RA PHARMACEUTICALS, INC. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937266

Oligomer-containing benzamide-based compounds

Nektar Therapeutics · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937228

Treatment of myocardial infarction by inhibiting the action of mAKAPβ

Anchored RSK3 Inhibitors, LLC · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937217

Method of inhibiting ABCG2 and related treatments

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937207

Targeted disruption of T cell receptor genes using talens

Sangamo Therapeutics, Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937196

Genomic sequence of avian paramyxovirus type 2 and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937159

Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

Lutonix, Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9937156

Modulation of MRTF-A activity in pathologic fibrosis and wound healing

The Board of Regents of the University of Texas System · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9938531

Compositions and methods for inhibiting expression of RRM2 genes

Arrowhead Pharmaceuticals, Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9943539

2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

Ionis Pharmaceuticals, Inc. · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9944927

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9944740

Sugar containing, amphiphilic copolymers

Regents of the University of Minnesota · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9944951

Chromosome 3p21.3 genes are tumor suppressors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9943601

Etanercept formulations stabilized with combinations of sugars and polyols

Coherus BioSciences, Inc. · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9944929

UNA single stranded oligomers for therapeutics

ARCTURUS THERAPEUTICS, INC. · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)